Vanguard Personalized Indexing Management, LLC Cabaletta Bio, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 19,379 shares of CABA stock, worth $42,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,379
Previous 18,413
5.25%
Holding current value
$42,246
Previous $40,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
99Shares Held
37.8MCall Options Held
154KPut Options Held
192K-
Black Rock Inc. New York, NY4.76MShares$10.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$8.65 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.92 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$6.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.02 Million1.29% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $63.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...